Global Injectable Pain Medication Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Injectable Pain Medication Revenue
1.4 Market Analysis by Type
1.4.1 Global Injectable Pain Medication Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.4.3 Central Analgesics
1.5 Market by Application
1.5.1 Global Injectable Pain Medication Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Recovery Center
1.6 Coronavirus Disease 2019 (Covid-19): Injectable Pain Medication Industry Impact
1.6.1 How the Covid-19 is Affecting the Injectable Pain Medication Industry
1.6.1.1 Injectable Pain Medication Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Injectable Pain Medication Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Injectable Pain Medication Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Injectable Pain Medication Market Perspective (2015-2026)
2.2 Injectable Pain Medication Growth Trends by Regions
2.2.1 Injectable Pain Medication Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Injectable Pain Medication Historic Market Share by Regions (2015-2020)
2.2.3 Injectable Pain Medication Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Injectable Pain Medication Market Growth Strategy
2.3.6 Primary Interviews with Key Injectable Pain Medication Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Injectable Pain Medication Players by Market Size
3.1.1 Global Top Injectable Pain Medication Players by Revenue (2015-2020)
3.1.2 Global Injectable Pain Medication Revenue Market Share by Players (2015-2020)
3.1.3 Global Injectable Pain Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Injectable Pain Medication Market Concentration Ratio
3.2.1 Global Injectable Pain Medication Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Injectable Pain Medication Revenue in 2019
3.3 Injectable Pain Medication Key Players Head office and Area Served
3.4 Key Players Injectable Pain Medication Product Solution and Service
3.5 Date of Enter into Injectable Pain Medication Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Injectable Pain Medication Historic Market Size by Type (2015-2020)
4.2 Global Injectable Pain Medication Forecasted Market Size by Type (2021-2026)
5 Injectable Pain Medication Breakdown Data by Application (2015-2026)
5.1 Global Injectable Pain Medication Market Size by Application (2015-2020)
5.2 Global Injectable Pain Medication Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Injectable Pain Medication Market Size (2015-2020)
6.2 Injectable Pain Medication Key Players in North America (2019-2020)
6.3 North America Injectable Pain Medication Market Size by Type (2015-2020)
6.4 North America Injectable Pain Medication Market Size by Application (2015-2020)
7 Europe
7.1 Europe Injectable Pain Medication Market Size (2015-2020)
7.2 Injectable Pain Medication Key Players in Europe (2019-2020)
7.3 Europe Injectable Pain Medication Market Size by Type (2015-2020)
7.4 Europe Injectable Pain Medication Market Size by Application (2015-2020)
8 China
8.1 China Injectable Pain Medication Market Size (2015-2020)
8.2 Injectable Pain Medication Key Players in China (2019-2020)
8.3 China Injectable Pain Medication Market Size by Type (2015-2020)
8.4 China Injectable Pain Medication Market Size by Application (2015-2020)
9 Japan
9.1 Japan Injectable Pain Medication Market Size (2015-2020)
9.2 Injectable Pain Medication Key Players in Japan (2019-2020)
9.3 Japan Injectable Pain Medication Market Size by Type (2015-2020)
9.4 Japan Injectable Pain Medication Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Injectable Pain Medication Market Size (2015-2020)
10.2 Injectable Pain Medication Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Injectable Pain Medication Market Size by Type (2015-2020)
10.4 Southeast Asia Injectable Pain Medication Market Size by Application (2015-2020)
11 India
11.1 India Injectable Pain Medication Market Size (2015-2020)
11.2 Injectable Pain Medication Key Players in India (2019-2020)
11.3 India Injectable Pain Medication Market Size by Type (2015-2020)
11.4 India Injectable Pain Medication Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Injectable Pain Medication Market Size (2015-2020)
12.2 Injectable Pain Medication Key Players in Central & South America (2019-2020)
12.3 Central & South America Injectable Pain Medication Market Size by Type (2015-2020)
12.4 Central & South America Injectable Pain Medication Market Size by Application (2015-2020)
13Key Players Profiles
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline Injectable Pain Medication Introduction
13.1.4 GlaxoSmithKline Revenue in Injectable Pain Medication Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Injectable Pain Medication Introduction
13.2.4 Merck Revenue in Injectable Pain Medication Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer Injectable Pain Medication Introduction
13.3.4 Pfizer Revenue in Injectable Pain Medication Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview and Its Total Revenue
13.4.3 Novartis Injectable Pain Medication Introduction
13.4.4 Novartis Revenue in Injectable Pain Medication Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview and Its Total Revenue
13.5.3 Sanofi Injectable Pain Medication Introduction
13.5.4 Sanofi Revenue in Injectable Pain Medication Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview and Its Total Revenue
13.6.3 Bayer Injectable Pain Medication Introduction
13.6.4 Bayer Revenue in Injectable Pain Medication Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Johson & Johson
13.7.1 Johson & Johson Company Details
13.7.2 Johson & Johson Business Overview and Its Total Revenue
13.7.3 Johson & Johson Injectable Pain Medication Introduction
13.7.4 Johson & Johson Revenue in Injectable Pain Medication Business (2015-2020)
13.7.5 Johson & Johson Recent Development
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Details
13.8.2 Boehringer Ingelheim Business Overview and Its Total Revenue
13.8.3 Boehringer Ingelheim Injectable Pain Medication Introduction
13.8.4 Boehringer Ingelheim Revenue in Injectable Pain Medication Business (2015-2020)
13.8.5 Boehringer Ingelheim Recent Development
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Details
13.9.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.9.3 Sun Pharmaceutical Injectable Pain Medication Introduction
13.9.4 Sun Pharmaceutical Revenue in Injectable Pain Medication Business (2015-2020)
13.9.5 Sun Pharmaceutical Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Injectable Pain Medication Key Market Segments
Table 2. Key Players Covered: Ranking by Injectable Pain Medication Revenue
Table 3. Ranking of Global Top Injectable Pain Medication Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Injectable Pain Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 6. Key Players of Central Analgesics
Table 7. COVID-19 Impact Global Market: (Four Injectable Pain Medication Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Injectable Pain Medication Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Injectable Pain Medication Players to Combat Covid-19 Impact
Table 12. Global Injectable Pain Medication Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Injectable Pain Medication Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Injectable Pain Medication Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Injectable Pain Medication Market Share by Regions (2015-2020)
Table 16. Global Injectable Pain Medication Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Injectable Pain Medication Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Injectable Pain Medication Market Growth Strategy
Table 22. Main Points Interviewed from Key Injectable Pain Medication Players
Table 23. Global Injectable Pain Medication Revenue by Players (2015-2020) (Million US$)
Table 24. Global Injectable Pain Medication Market Share by Players (2015-2020)
Table 25. Global Top Injectable Pain Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Pain Medication as of 2019)
Table 26. Global Injectable Pain Medication by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Injectable Pain Medication Product Solution and Service
Table 29. Date of Enter into Injectable Pain Medication Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 32. Global Injectable Pain Medication Market Size Share by Type (2015-2020)
Table 33. Global Injectable Pain Medication Revenue Market Share by Type (2021-2026)
Table 34. Global Injectable Pain Medication Market Size Share by Application (2015-2020)
Table 35. Global Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 36. Global Injectable Pain Medication Market Size Share by Application (2021-2026)
Table 37. North America Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Injectable Pain Medication Market Share (2019-2020)
Table 39. North America Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 40. North America Injectable Pain Medication Market Share by Type (2015-2020)
Table 41. North America Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 42. North America Injectable Pain Medication Market Share by Application (2015-2020)
Table 43. Europe Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Injectable Pain Medication Market Share (2019-2020)
Table 45. Europe Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Injectable Pain Medication Market Share by Type (2015-2020)
Table 47. Europe Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Injectable Pain Medication Market Share by Application (2015-2020)
Table 49. China Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 50. China Key Players Injectable Pain Medication Market Share (2019-2020)
Table 51. China Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 52. China Injectable Pain Medication Market Share by Type (2015-2020)
Table 53. China Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 54. China Injectable Pain Medication Market Share by Application (2015-2020)
Table 55. Japan Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Injectable Pain Medication Market Share (2019-2020)
Table 57. Japan Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Injectable Pain Medication Market Share by Type (2015-2020)
Table 59. Japan Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Injectable Pain Medication Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Injectable Pain Medication Market Share (2019-2020)
Table 63. Southeast Asia Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Injectable Pain Medication Market Share by Type (2015-2020)
Table 65. Southeast Asia Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Injectable Pain Medication Market Share by Application (2015-2020)
Table 67. India Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 68. India Key Players Injectable Pain Medication Market Share (2019-2020)
Table 69. India Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 70. India Injectable Pain Medication Market Share by Type (2015-2020)
Table 71. India Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 72. India Injectable Pain Medication Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Injectable Pain Medication Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Injectable Pain Medication Market Share (2019-2020)
Table 75. Central & South America Injectable Pain Medication Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Injectable Pain Medication Market Share by Type (2015-2020)
Table 77. Central & South America Injectable Pain Medication Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Injectable Pain Medication Market Share by Application (2015-2020)
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Product
Table 107. Bayer Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 108. Bayer Recent Development
Table 109. Johson & Johson Company Details
Table 110. Johson & Johson Business Overview
Table 111. Johson & Johson Product
Table 112. Johson & Johson Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 113. Johson & Johson Recent Development
Table 114. Boehringer Ingelheim Business Overview
Table 115. Boehringer Ingelheim Product
Table 116. Boehringer Ingelheim Company Details
Table 117. Boehringer Ingelheim Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 118. Boehringer Ingelheim Recent Development
Table 119. Sun Pharmaceutical Company Details
Table 120. Sun Pharmaceutical Business Overview
Table 121. Sun Pharmaceutical Product
Table 122. Sun Pharmaceutical Revenue in Injectable Pain Medication Business (2015-2020) (Million US$)
Table 123. Sun Pharmaceutical Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Injectable Pain Medication Market Share by Type: 2020 VS 2026
Figure 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Features
Figure 3. Central Analgesics Features
Figure 4. Global Injectable Pain Medication Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Recovery Center Case Studies
Figure 8. Injectable Pain Medication Report Years Considered
Figure 9. Global Injectable Pain Medication Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Injectable Pain Medication Market Share by Regions: 2020 VS 2026
Figure 11. Global Injectable Pain Medication Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Injectable Pain Medication Market Share by Players in 2019
Figure 14. Global Top Injectable Pain Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Pain Medication as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Injectable Pain Medication Revenue in 2019
Figure 16. North America Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Injectable Pain Medication Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. GlaxoSmithKline Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 25. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Merck Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 31. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sanofi Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 33. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bayer Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 35. Johson & Johson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Johson & Johson Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 37. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Boehringer Ingelheim Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 39. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sun Pharmaceutical Revenue Growth Rate in Injectable Pain Medication Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed